학술논문

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
Document Type
Academic Journal
Source
Annals of Oncology. Nov 01, 2017 28(11):2813-2819
Subject
Language
English
ISSN
0923-7534